title: [The clinical use of levosulpiride in retinal fluorangiography].
abstract: The value of administering 25 mg of levosulpiride per os approximately one hour before the sodium fluorescein bolus used in fluorangiography is assessed in order to avoid to the onset of nausea and/or vomiting during and after the test. The study was performed in 35 patients. No nausea and/or vomiting was observed in over 90% of cases treated.
authors.affiliation: Servizio di Anestesia e Rianimazione, Ospedale Mauriziano Umberto I, Torino.
authors.forename: M
authors.initials: M
authors.lastname: Torrero
authors.forename: A
authors.initials: A
authors.lastname: Rosina
authors.forename: D
authors.initials: D
authors.lastname: Paneghel
authors.forename: L
authors.initials: L
authors.lastname: Bianchetti
authors.forename: L
authors.initials: L
authors.lastname: Fusi
authors.forename: M
authors.initials: M
authors.lastname: Vanzetti
mesh_terms: D000328:Adult; D000368:Aged; D019793:Fluorescein; D005451:Fluorescein Angiography; D005452:Fluoresceins / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D011859:Radiography; D012171:Retinal Vessels / Q000000981:diagnostic imaging; D013469:Sulpiride / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D005452:Fluoresceins; D013469:Sulpiride; D019793:Fluorescein
vernacular_title: Considerazione sull'uso clinico della levo-sulpiride nella fluorangiografia retinica.